Skip to main content
. 2023 Oct 10;26(1):23–29. doi: 10.7461/jcen.2023.E2023.05.002

Table 5.

Summary of cases that showed positive TCD embolic signals after PED deployment

Pt Age Gender Aneurysm size #PED Coiling PRU % inhibition Initial
Followup
Final
Outcome
mES/h Mgmt mES/h Mgmt mES /h Mgmt
1 71 1 20 1 N 74 18.7 3 1 0 1 0 0 intact
2 72 2 17 2 Y 199 34.1 3 1 0 1 0 1 intact
3 47 1 3.5 1 N 145 39.1 3 1 0 1 0 1 intact
4 51 1 11 1 Y 119 60.2 3 1 0 1 0 1 intact
5 42 1 8 1 N 172 33.3 6 1 297 4 0 1 intact
6 63 2 8 1 Y 199 27.1 6 1 18 4 0 1 intact
7 42 2 8 1 N 152 8.4 6 1 0 1 0 1 intact
8 44 1 3.5 1 N 78 70.1 9 1 0 1 0 1 intact
9 70 2 14 1 N 217 20.8 9 4 0 1 0 1 intact
10 30 2 25 1 Y 130 30.1 18 2 12 5 18 5 intact
11 49 1 7.2 1 N 139 46.1 42 2 51 2 0 1 intact
12 48 1 6.5 1 N 105 70.8 303 24 0 1 0 1 intact

Mgmt: 1=Repeat TCD only, 2=Heparin, 3=Ticagelor, 4=Reload ASA/Piavix, 5=Multiple Meds

TCD, transcranial Doppler; PED, pipeline embolization device; PRU, P2Y12 reaction units